Mutational analysis of sites in the translational regulator, PHAS-I, that are selectively phosphorylated by mTOR
被引:36
作者:
Yang, DQ
论文数: 0引用数: 0
h-index: 0
机构:Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA
Yang, DQ
Brunn, GJ
论文数: 0引用数: 0
h-index: 0
机构:Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA
Brunn, GJ
Lawrence, JC
论文数: 0引用数: 0
h-index: 0
机构:
Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USAUniv Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA
Lawrence, JC
[1
]
机构:
[1] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA
[2] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA
来源:
FEBS LETTERS
|
1999年
/
453卷
/
03期
关键词:
mTOR;
mitogen-associated protein kinase;
4E-BP1;
mRNA translation initiation;
D O I:
10.1016/S0014-5793(99)00762-0
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Results obtained with PHAS-I proteins having Ser to Ala mutations in the five known phosphorylation sites indicate that mTOR preferentially phosphorylates Thr36 and Thr45, The effects of phosphorylating these sites on eIF4E binding were assessed in a far-Western analysis with a labeled eIF4E probe. Phosphorylation of Thr36 only slightly attenuated binding of PHAS-I to eIF4E, while phosphorylation of Thr45 markedly inhibited binding. Phosphorylation of neither site affected the electrophoretic mobility of the protein, indicating that results of studies that rely solely on a gel-shift assay to assess changes in PHAS-I phosphorylation must be interpreted with caution. (C) 1999 Federation of European Biochemical Societies.